zepbound tirzepatide injection eli lilly Lilly's available in two vials for self-pay patients Eli Lilly to release single-dose

Zhou J, Liu H, Zhang T, Wang Z, Zhang J, Lu Y, et al

It is essentially a chain of 39 amino-acid building blocks, its shape cleverly designed to fit into the receptors of three different hormones all at once: GLP-1, GIP, and glucagon

Newer options appear more potent.(20) Cardiovascular data Only certain GLP-1s have proven cardiovascular benefits for at-risk diabetics thus far

Tirzepatide (Mounjaro and Zepbound) at the 15 mg dose showed comparable lean-mass loss in pattern but modestly less in proportion (approximately 25% of total weight loss as lean mass

What factors should we weigh in our consideration of the utility of GLP-1 agonists